0 NASDAQ Companies - August 20, 2019Mersana Therapeutics Announces Initiation of Expansion Study of XMT-1536 in Patients with Platinum-Resistant Ovarian Cancer and Non-Small Cell Lung CancerRead More
0 NASDAQ Companies - August 20, 2019Enrollment in the Independent Investigator-Sponsored Phase III Metastatic Pancreatic Study ACELARATE Has Been Suspended Following a Prespecified Futility AnalysisRead More
0 NASDAQ Companies - August 20, 2019Super League Gaming Sets September 2019 Conference ScheduleRead More
0 NASDAQ Companies - August 20, 2019Clearfield Sets September 2019 Financial Conference ScheduleRead More
0 NASDAQ Companies - August 20, 2019Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business UpdateRead More
0 NASDAQ Companies - August 20, 2019Duluth Holdings Inc. to Report Second Quarter 2019 Financial Results on September 12Read More
0 NASDAQ Companies - August 20, 2019Outlook Therapeutics Completes Patient Enrollment for NORSE 1 a Phase 3 Clinical Trial for ONS-5010 in Wet AMDRead More
0 NASDAQ Companies - August 20, 2019Qumu to Present at the 8th Annual Gateway Conference on September 4, 2019Read More
0 NASDAQ Companies - August 20, 2019Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare ConferenceRead More
0 NASDAQ Companies - August 20, 2019Proofpoint to Offer $750 Million Convertible Senior Notes due 2024Read More
